Loading...
Loading...
Application UK00003201166 · Registered
| Application Number | UK00003201166 |
| Status | Registered |
| Owner | Syros Pharmaceuticals, Inc. |
| Filed | 2013-04-23 |
| Registered | 2017-03-10 |
| Renewal Due | 2033-04-23 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. SYROS is currently a registered UK trademark, with renewal due on 2033-04-23. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations and compounds for use in the treatment of cancer; pharmaceutical preparations and compounds for inhibition of transcriptional regulators.
Consulting services in the field of pharmaceutical research and development; research and development of pharmaceuticals and compounds for the treatment of cancer; research and development of pharmaceuticals and compounds for inhibition of transcriptional regulators; research and development of pharmaceutical preparations and medicines for others.
'SYROS' is a registered trademark on the UK IPO register, owned by Syros Pharmaceuticals, Inc.. The application (UK00003201166) was filed on 23 April 2013 and registered on 10 March 2017. The registration is set to expire on 23 April 2033.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services).
The trademark is represented by HGF Limited.
UK trademark UK00003201166 for the mark 'SYROS' in Class 5, 42 is recorded on the UK IPO register as owned by Syros Pharmaceuticals, Inc.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00003201166 for the mark 'SYROS' as registered.
UK trademark UK00003201166 for the mark 'SYROS' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services). The filed specification reads: Class 5: Pharmaceutical preparations and compounds for use in the treatment of cancer; pharmaceutical preparations and compounds for inhibition of transcriptional regulators. | Class 42: Consulting services in the field of pharmaceutical research and development; research and development of pharmaceuticals and compo…
UK trademark UK00003201166 for the mark 'SYROS' was filed at the UK IPO on 23 April 2013 and registered on 10 March 2017.
The UK IPO first published / advertised UK trademark UK00003201166 for the mark 'SYROS' on 23 December 2016.
UK trademark UK00003201166 for the mark 'SYROS' is currently recorded as valid until 23 April 2033, at which point it will need to be renewed with the UK IPO to remain in force.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.